A detailed history of Macquarie Group LTD transactions in Becton Dickinson & CO stock. As of the latest transaction made, Macquarie Group LTD holds 101,758 shares of BDX stock, worth $22.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
101,758
Previous 96,650 5.29%
Holding current value
$22.6 Million
Previous $22.6 Million 8.61%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$221.47 - $242.41 $1.13 Million - $1.24 Million
5,108 Added 5.29%
101,758 $24.5 Million
Q2 2024

Aug 09, 2024

BUY
$225.07 - $246.17 $1.77 Million - $1.93 Million
7,854 Added 8.84%
96,650 $22.6 Million
Q1 2024

May 14, 2024

BUY
$233.45 - $247.73 $3.06 Million - $3.25 Million
13,127 Added 17.35%
88,796 $22 Million
Q4 2023

Feb 14, 2024

BUY
$232.24 - $267.23 $2.22 Million - $2.55 Million
9,561 Added 14.46%
75,669 $18.5 Million
Q3 2023

Nov 14, 2023

BUY
$254.9 - $283.59 $8.28 Million - $9.22 Million
32,500 Added 96.7%
66,108 $17.1 Million
Q2 2023

Aug 14, 2023

SELL
$238.39 - $265.32 $352,817 - $392,673
-1,480 Reduced 4.22%
33,608 $8.87 Million
Q1 2023

May 15, 2023

BUY
$229.71 - $259.35 $87,519 - $98,812
381 Added 1.1%
35,088 $8.69 Million
Q4 2022

Feb 21, 2023

BUY
$218.29 - $256.91 $576,940 - $679,013
2,643 Added 8.24%
34,707 $8.83 Million
Q3 2022

Nov 14, 2022

SELL
$51.03 - $264.23 $829,696 - $4.3 Million
-16,259 Reduced 33.65%
32,064 $7.15 Million
Q2 2022

Aug 15, 2022

SELL
$234.74 - $275.42 $1.34 Million - $1.57 Million
-5,704 Reduced 10.56%
48,323 $11.9 Million
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $999,898 - $1.11 Million
-4,104 Reduced 7.06%
54,027 $14.4 Million
Q4 2021

Feb 11, 2022

BUY
$230.08 - $250.94 $3.45 Million - $3.76 Million
15,002 Added 34.78%
58,131 $14.6 Million
Q3 2021

Nov 12, 2021

BUY
$232.72 - $256.47 $77,728 - $85,660
334 Added 0.78%
43,129 $10.6 Million
Q2 2021

Aug 13, 2021

BUY
$232.65 - $254.58 $1.52 Million - $1.66 Million
6,520 Added 17.97%
42,795 $10.4 Million
Q1 2021

May 14, 2021

SELL
$232.09 - $256.88 $298,699 - $330,604
-1,287 Reduced 3.43%
36,275 $8.82 Million
Q4 2020

Feb 16, 2021

SELL
$221.92 - $245.94 $7,323 - $8,116
-33 Reduced 0.09%
37,562 $9.4 Million
Q3 2020

Nov 13, 2020

BUY
$215.77 - $276.76 $94,723 - $121,497
439 Added 1.18%
37,595 $8.75 Million
Q2 2020

Aug 11, 2020

SELL
$219.9 - $263.41 $6.17 Million - $7.39 Million
-28,041 Reduced 43.01%
37,156 $8.89 Million
Q1 2020

May 15, 2020

SELL
$195.69 - $279.01 $9.92 Million - $14.1 Million
-50,695 Reduced 43.74%
65,197 $15 Million
Q4 2019

Feb 14, 2020

BUY
$236.45 - $266.82 $4.27 Million - $4.81 Million
18,040 Added 18.44%
115,892 $31.5 Million
Q3 2019

Nov 14, 2019

SELL
$230.58 - $256.08 $1.84 Million - $2.05 Million
-7,994 Reduced 7.55%
97,852 $24.8 Million
Q2 2019

Aug 14, 2019

SELL
$217.4 - $246.08 $1.47 Million - $1.66 Million
-6,750 Reduced 5.99%
105,846 $26.7 Million
Q1 2019

May 15, 2019

BUY
$206.05 - $248.17 $4.97 Million - $5.99 Million
24,129 Added 27.27%
112,596 $28.1 Million
Q4 2018

Feb 15, 2019

SELL
$204.73 - $257.93 $839,393 - $1.06 Million
-4,100 Reduced 4.43%
88,467 $19.9 Million
Q3 2018

Nov 15, 2018

SELL
$233.07 - $256.0 $4.97 Million - $5.45 Million
-21,307 Reduced 18.71%
92,567 $24.2 Million
Q2 2018

Aug 14, 2018

BUY
$208.1 - $233.85 $561,870 - $631,395
2,700 Added 2.43%
113,874 $27.3 Million
Q1 2018

May 11, 2018

BUY
$205.46 - $240.27 $2.34 Million - $2.74 Million
11,407 Added 11.43%
111,174 $24.1 Million
Q4 2017

Feb 15, 2018

BUY
$189.0 - $222.64 $1.19 Million - $1.41 Million
6,314 Added 6.76%
99,767 $23.1 Million
Q3 2017

Nov 08, 2017

BUY
$186.89 - $198.9 $17.5 Million - $18.6 Million
93,453
93,453 $18.3 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.